expert discusses the role of pd-l1 expression as a predictive biomarker in urothelial carcinoma
Published 5 years ago • 423 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
3:50
the role of pd-l1: is it accurate enough as a biomarker for immunotherapy response?
-
3:32
value of pd-l1 testing in metastatic urothelial cancer
-
2:36
pd-l1 expression as a predictive biomarker
-
1:30
hhla2 vs pd-l1 expression in urothelial tumors
-
1:32
utility of pd-l1 as a biomarker in bladder cancer
-
2:41
should pd-l1 be used as a biomarker for immunotherapy in bladder cancer?
-
1:24
dr. lilenbaum on pd-l1 as a predictive biomarker for immunotherapy in lung cancer
-
6:03
pd-l1 expression in metastatic urothelial cancer
-
1:12
dr. sharma on pd-l1 as biomarker for immunotherapy in bladder cancer
-
1:25
dr. mcdermott discusses pd-l1 expression in kidney cancer
-
1:07
exploring the role of biomarkers in patient selection for immunotherapy in bladder cancer
-
7:55
pd-l1 expression in bladder cancer
-
1:47
dr. siefker-radtke on pd-l1 as a biomarker in bladder cancer
-
10:49
is pd-l1 really a predictive biomarker?
-
2:52
pd-l1 and tmb as biomarkers in the imvigor211 trial of atezolizumab vs. chemo for bladder cancer
-
6:49
the role of biomarkers in bladder cancer
-
14:16
new emerging treatment options and targeted therapies for bladder cancer
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
1:06
pd-l1: an important, but imperfect biomarker